AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H1242-H1247, 2004. First published November 20, 2003; doi:10.1152/ajpheart.00437.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/4/H1242    most recent
00437.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mukherjee, R.
Right arrow Articles by Saul, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mukherjee, R.
Right arrow Articles by Saul, J. P.

Myocardial remodeling after discrete radiofrequency injury: effects of tissue inhibitor of matrix metalloproteinase-1 gene deletion

Rupak Mukherjee,1,2 Andrea M. Parkhurst,1 Joseph T. Mingoia,1 Sarah E. Sweterlitsch,1 Jennifer S. Leiser,1 G. Patricia Escobar,1 Francis G. Spinale,1,2 and J. Philip Saul2

Divisions of 1Cardiothoracic Surgery and 2Pediatric Cardiology, Medical University of South Carolina, Charleston, South Carolina 29425

Submitted 15 May 2003 ; accepted in final form 14 November 2003

Discrete myocardial lesions created through the delivery of radiofrequency (RF) energy can expand; however, the mechanisms have not been established. Matrix metalloproteinases (MMPs) play an important role in myocardial remodeling, and MMP activity can be regulated by the tissue inhibitors of the metalloproteinases (TIMPs). This study examined the role of TIMP-1 in postinjury myocardial remodeling. Lesions were created on the left ventricular (LV) epicardium of wild-type (WT, 8–12 wk, 129SVE) and age-matched TIMP-1 gene-deficient (timp-1–/–) mice through the delivery of RF current (80°C, 30 s). Heart mass, LV scar volumes, and collagen content were measured at 1 h and 3, 7, and 28 days postinjury (n = 10 each). Age-matched, nonablated mice were used as reference controls (n = 5). Heart mass indexed to tibial length increased in WT and timp-1–/– mice but was greater in the timp-1–/– mice by 7 days. Scar volumes increased in a time-dependent manner in both groups but were higher in the timp-1–/– mice than the WT mice at 7 days (1.48 ± 0.09 vs. 1.20 ± 0.11 mm3·mg–1·mm, P < 0.05) and remained higher at 28 days. In the remote myocardium, wall thickness was greater and relative collagen content was lower in the timp-1–/– mice at 28 days postinjury. Discrete myocardial RF lesions expand in a time-dependent manner associated with myocyte hypertrophy remote to the scar. Moreover, postinjury myocardial remodeling was more extensive with TIMP-1 gene deletion. Thus TIMP-1 either directly or through modulation of MMP activity may regulate myocardial remodeling following infliction of a discrete injury.

myocardial remodeling; tissue inhibitors of metalloproteinases-1; mouse



Address for reprint requests and other correspondence: R. Mukherjee, Cardiothoracic Surgery, Strom Thurmond Research Bldg., 770 MUSC Complex, Suite 625, Medical Univ. of South Carolina, Charleston, SC 29425 (E-mail: mukherr{at}musc.edu).




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. K. Mani, S. Balasubramanian, J. A. Zavadzkas, L. B. Jeffords, W. T. Rivers, M. R. Zile, R. Mukherjee, F. G. Spinale, and D. Kuppuswamy
Calpain inhibition preserves myocardial structure and function following myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1744 - H1751.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Janssens and H. R. Lijnen
What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Cardiovasc Res, February 15, 2006; 69(3): 585 - 594.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Vanhoutte, M. Schellings, Y. Pinto, and S. Heymans
Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: A temporal and spatial window
Cardiovasc Res, February 15, 2006; 69(3): 604 - 613.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. K. Sukhova, B. Wang, P. Libby, J.-H. Pan, Y. Zhang, A. Grubb, K. Fang, H. A. Chapman, and G.-P. Shi
Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E-Null Mice
Circ. Res., February 18, 2005; 96(3): 368 - 375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.